日本語English简体中文 繁體中文

09966 ALPHAMAB ONCOLOGYALPHAMAB-BHong Kong Stock Exchange

10 posts

ALPHAMAB ONCOLOGY (09966) at a glance

Code
09966
Company
ALPHAMAB ONCOLOGY
Local name
ALPHAMAB-B
Market
Hong Kong Stock Exchange
Share price
HK$5.95 -0.21 (-3.33%) Nov 12 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

ALPHAMAB ONCOLOGY (09966) Stock Price HistoryNear a 52-week low

ALPHAMAB ONCOLOGY closed at HK$5.95 on Nov 12, 2026, −17.2% over 1 month, −40.1% over 1 year.

2026-10-23 開示要取引/内部情報(インサイド・インフォメーション) DISCLOSEABLE TRANSACTION…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS OF TWO PHASE III CL… / 事業の状況 VOLUNTARY ANNOUNCEMENT - RESULTS OF A PHASE I/II CLINICAL STUDY OF J… / 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH UPDATES OF JSKN003 PRESENTE…2026-10-27 株式報酬制度 GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME2026-10-28 事業の状況 VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE III CLINICAL S…2026-10-29 開示要取引 SUPPLEMENTARY ANNOUNCEMENT ON DISCLOSEABLE TRANSACTION2026-11-02 事業の状況 VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY THE FDA FOR A PHASE I CLINI…2026-11-12 その他 VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF FINANCIAL OFFICERHK$7.27HK$5.95Oct 12Nov 12
Price5-day MA25-day MAHang Seng IndexDisclosures
1-Month HighHK$7.27Oct 21
1-Month LowHK$5.95Nov 12
1-Week Change−10.7%vs Nov 5
1-Month Change−17.2%vs Oct 12

If you had invested HK$10,000 1 month ago, it would be worth HK$8,280 today (−17.2%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −1.1%, while this stock moved −17.2%.

Last 10 Trading Days

DateCloseChange% Change
Nov 12 (Thu)HK$5.95−0.21−3.33%
Nov 11 (Wed)HK$6.15−0.09−1.52%
Nov 10 (Tue)HK$6.25−0.09−1.50%
Nov 9 (Mon)HK$6.34+0.09+1.36%
Nov 6 (Fri)HK$6.26−0.40−6.01%
Nov 5 (Thu)HK$6.66+0.11+1.68%
Nov 4 (Wed)HK$6.55+0.40+6.51%
Nov 3 (Tue)HK$6.15+0.07+1.15%
Nov 2 (Mon)HK$6.08−0.14−2.25%
Oct 30 (Fri)HK$6.22−0.28−4.24%
2026-09-24 中間報告書 2026 INTERIM REPORT2026-10-23 開示要取引/内部情報(インサイド・インフォメーション) DISCLOSEABLE TRANSACTION…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS OF TWO PHASE III CL… / 事業の状況 VOLUNTARY ANNOUNCEMENT - RESULTS OF A PHASE I/II CLINICAL STUDY OF J… / 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH UPDATES OF JSKN003 PRESENTE…2026-10-27 株式報酬制度 GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME2026-10-28 事業の状況 VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE III CLINICAL S…2026-10-29 開示要取引 SUPPLEMENTARY ANNOUNCEMENT ON DISCLOSEABLE TRANSACTION2026-11-02 事業の状況 VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY THE FDA FOR A PHASE I CLINI…2026-11-12 その他 VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF FINANCIAL OFFICERHK$9.12HK$5.95Aug 12Nov 12
Price5-day MA25-day MAHang Seng IndexDisclosures
3-Month HighHK$9.12Aug 27
3-Month LowHK$5.95Nov 12
1-Month Change−17.2%vs Oct 12
3-Month Change−29.6%vs Aug 12

If you had invested HK$10,000 3 months ago, it would be worth HK$7,044 today (−29.6%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −5.6%, while this stock moved −29.6%.

Last 10 Trading Days

DateCloseChange% Change
Nov 12 (Thu)HK$5.95−0.21−3.33%
Nov 11 (Wed)HK$6.15−0.09−1.52%
Nov 10 (Tue)HK$6.25−0.09−1.50%
Nov 9 (Mon)HK$6.34+0.09+1.36%
Nov 6 (Fri)HK$6.26−0.40−6.01%
Nov 5 (Thu)HK$6.66+0.11+1.68%
Nov 4 (Wed)HK$6.55+0.40+6.51%
Nov 3 (Tue)HK$6.15+0.07+1.15%
Nov 2 (Mon)HK$6.08−0.14−2.25%
Oct 30 (Fri)HK$6.22−0.28−4.24%
2026-09-24 中間報告書 2026 INTERIM REPORT2026-10-23 開示要取引/内部情報(インサイド・インフォメーション) DISCLOSEABLE TRANSACTION…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS OF TWO PHASE III CL… / 事業の状況 VOLUNTARY ANNOUNCEMENT - RESULTS OF A PHASE I/II CLINICAL STUDY OF J… / 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH UPDATES OF JSKN003 PRESENTE…2026-10-27 株式報酬制度 GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME2026-10-28 事業の状況 VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE III CLINICAL S…2026-10-29 開示要取引 SUPPLEMENTARY ANNOUNCEMENT ON DISCLOSEABLE TRANSACTION2026-11-02 事業の状況 VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY THE FDA FOR A PHASE I CLINI…2026-11-12 その他 VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF FINANCIAL OFFICERHK$9.85HK$5.95May 12Nov 12
Price25-day MA75-day MAHang Seng IndexDisclosures
6-Month HighHK$9.85May 26
6-Month LowHK$5.95Nov 12
3-Month Change−29.6%vs Aug 12
6-Month Change−37.9%vs May 12

If you had invested HK$10,000 6 months ago, it would be worth HK$6,212 today (−37.9%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −8.9%, while this stock moved −37.9%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026HK$5.95−4.3%
Oct 2026HK$6.22−26.4%
Sep 2026HK$8.45−5.7%
Aug 2026HK$8.97+20.0%
Jul 2026HK$7.47+7.5%
Jun 2026HK$6.95−23.6%
May 2026HK$9.10−11.7%
2026-09-24 中間報告書 2026 INTERIM REPORT2026-10-23 開示要取引/内部情報(インサイド・インフォメーション) DISCLOSEABLE TRANSACTION…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS OF TWO PHASE III CL… / 事業の状況 VOLUNTARY ANNOUNCEMENT - RESULTS OF A PHASE I/II CLINICAL STUDY OF J… / 事業の状況 VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH UPDATES OF JSKN003 PRESENTE…2026-10-27 株式報酬制度 GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME2026-10-28 事業の状況 VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE III CLINICAL S…2026-10-29 開示要取引 SUPPLEMENTARY ANNOUNCEMENT ON DISCLOSEABLE TRANSACTION2026-11-02 事業の状況 VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY THE FDA FOR A PHASE I CLINI…2026-11-12 その他 VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF FINANCIAL OFFICERHK$11.99HK$5.95Nov 12Nov 12
Price25-day MA75-day MAHang Seng IndexDisclosures
52-Week HighHK$11.99Apr 16
52-Week LowHK$5.95Nov 12
Year to Date−39.5%vs Dec 31
From 52-Week High−50.4%Apr 16

If you had invested HK$10,000 1 year ago, it would be worth HK$5,993 today (−40.1%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −10.8%, while this stock moved −40.1%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026HK$5.95−4.3%
Oct 2026HK$6.22−26.4%
Sep 2026HK$8.45−5.7%
Aug 2026HK$8.97+20.0%
Jul 2026HK$7.47+7.5%
Jun 2026HK$6.95−23.6%
May 2026HK$9.10−11.7%
Apr 2026HK$10.30+32.1%
Mar 2026HK$7.80−10.4%
Feb 2026HK$8.71−2.2%
Jan 2026HK$8.91−9.3%
Dec 2025HK$9.82−9.2%
Nov 2025HK$10.81−6.0%
HK$15.30HK$2.17Nov 13, 2023Nov 12, 2026
Price13-week MA26-week MAHang Seng Index
3-Year HighHK$15.30Sep 29, 2025
3-Year LowHK$2.17Jul 22, 2024
Annualized Return−1.8%
Max Drawdown−67.7%

If you had invested HK$10,000 3 years ago, it would be worth HK$9,482 today (−5.2%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved +37.6%, while this stock moved −5.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)HK$5.95−39.5%
2025HK$9.82―
HK$19.14HK$2.17Nov 15, 2021Nov 12, 2026
Price13-week MA26-week MAHang Seng Index
5-Year HighHK$19.14Nov 22, 2021
5-Year LowHK$2.17Jul 22, 2024
Annualized Return−20.1%
Max Drawdown−88.7%

If you had invested HK$10,000 5 years ago, it would be worth HK$3,270 today (−67.3%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −4.2%, while this stock moved −67.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)HK$5.95−39.5%
2025HK$9.82―
HK$26.55HK$2.17Dec 9, 2019Nov 12, 2026
Price1-year MA2-year MAHang Seng Index
All-Time HighHK$26.55Jul 2021
All-Time LowHK$2.17Jul 2024
Total Change−58.4%vs Dec 2019
Annualized Return−11.9%

If you had invested HK$10,000 in Dec 2019, it would be worth HK$4,157 today (−58.4%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −8.1%, while this stock moved −58.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)HK$5.95−37.9%
2025HK$9.58+169.1%
2024HK$3.56−46.4%
2023HK$6.64−38.5%
2022HK$10.80−20.6%
2021HK$13.60−17.3%
2020HK$16.44+19.1%
2019HK$13.80―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Dec 2019). Please check the latest prices before trading.

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.10 Disclosure 2026/11/12 09:00
その他
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF FINANCIAL OFFICER
Delete
No.9 Disclosure 2026/11/02 13:00
事業の状況
VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY THE FDA FOR A PHASE I CLINICAL STUDY OF JSKN021
Delete
No.8 Disclosure 2026/10/29 17:40
開示要取引
SUPPLEMENTARY ANNOUNCEMENT ON DISCLOSEABLE TRANSACTION
Delete
No.7 Disclosure 2026/10/28 21:55
事業の状況
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE III CLINICAL STUDY OF JSKN033 MONOTHERAPY FOR THE TREATMENT OF CERVICAL CANCER
Delete
No.6 Disclosure 2026/10/27 22:36
株式報酬制度
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
Delete
No.5 Disclosure 2026/10/26 20:30
事業の状況
VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH UPDATES OF JSKN003 PRESENTED AT THE 2026 ESMO CONGRESS
Delete
No.4 Disclosure 2026/10/26 13:15
事業の状況
VOLUNTARY ANNOUNCEMENT - RESULTS OF A PHASE I/II CLINICAL STUDY OF JSKN033 IN PATIENTS WITH CC FOLLOWING FAILURE OF STANDARD TREATMENT WERE PRESENTED AT THE 2026 ESMO CONGRESS AS A RAPID ORAL PRESENTATION
Delete
No.3 Disclosure 2026/10/26 13:10
事業の状況
VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS OF TWO PHASE III CLINICAL STUDIES OF ANBENITAMAB (KN026) WERE PRESENTED AT THE 2026 ESMO CONGRESS AS LBA ORAL PRESENTATIONS
Delete
No.2 Disclosure 2026/10/23 22:00
開示要取引/内部情報(インサイド・インフォメーション)
DISCLOSEABLE TRANSACTION - EXERCISE OF WARRANT TO SUBSCRIBE FOR PREFERRED STOCK OF PATHOS AI, INC.
Delete
No.1 Disclosure 2026/09/24 22:33
中間報告書
2026 INTERIM REPORT
Delete

Write on the ALPHAMAB ONCOLOGY board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English